Options Brief: Myriad Genetics, Inc.

Shares of Myriad Genetics, Inc. MYGN are higher on the session by 0.35%, trading at $22.87. Overall put volume is now running at 4.82x the daily average, with 3% of all puts traded being purchases on the offer. 3,038 contracts have traded on the session so far. Myriad Genetics, Inc. is a molecular diagnostic company focused on developing and marketing novel predictive medicine, personalized medicine and prognostic medicine products.